Background and purpose: Burn and surgical wounds are associated with distinct inflammatory responses, and conventional treatments such as mupirocin alone may be insufficient. This study aimed to compare the effects of mupirocin and silver nanoparticle (Nano)-based ointment with Arnebia euchroma (AE; Abukhalsa) ointment on inflammatory markers IL-1β and IL-10 in rat burn and full-thickness longitudinal incisional wound models, and to evaluate reductions in wound-related outcomes, including infection, discharge, inflammation, and scab formation.
Materials and methods: A controlled in vivo experimental study was conducted using 72 male Wistar rats (weighing 160-210 g) with two wound models: deep second-degree burn (7 groups of 6 rats) and full-thickness longitudinal incision wounds (5 groups of 6 rats). Treatment groups received ointments containing 2% mupirocin, 1% silver sulfadiazine (SSD), 2% and 5% AE, and 2% and 5% Nano formulations. Dressings were changed daily, and clinical signs were assessed on days 3, 7, 14, and 21 using a 0-2 scoring system. Serum levels of IL-1β and IL-10 were measured on days 7 and 21 using ELISA. Data were analysed using one-way analysis of variance (ANOVA) and Tukey’s post hoc test in SPSS version 24.
Results: Nano 5% ointment in burn wounds demonstrated the lowest discharge (mean score = 0.001) and infection score (mean score = 0.001), while Nano 2% ointment in surgical wounds showed greater reductions in discharge, infection, inflammation, and scab formation compared with AE 5% (p < 0.05). IL-1β levels in the Nano 2% and AE 5% groups were significantly decreased (p < 0.01), while IL-10 levels were increased, indicating potential modulation of the inflammatory response.
Conclusion: Silver nanoparticle formulations demonstrated promising wound-healing effects in this experimental model compared with mupirocin and AE. Nano 5% for burn wounds and Nano 2% for full-thickness longitudinal incision wounds showed greater potential for improving wound outcomes through reduced discharge, infection, and modulation of inflammatory cytokines. Further clinical studies are required to determine their effectiveness in human wound management.